|The National Institutes of Health Center for Scientific Review has chosen UT Arlington assistant biology professor Julian Hurdle to serve on a prestigious study section, one of the bodies that reviews grant applications, makes recommendations and surveys the status of research in a particular field.
Hurdle, a specialist in molecular microbiology and bacterial infectious diseases, will serve on the Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section through June 30, 2017.
"Dr. Hurdle is an accomplished researcher who is working hard to build a better understanding of the role bacteria play in disease," said Pamela Jansma, dean of the College of Science. "We are pleased to see him recognized by his colleagues and take on this active role in helping to determine where important research funding flows."
Hurdle joined the UT Arlington College of Science in 2010 and, in 2011, he was awarded a five-year, $1.9 million research grant from the National Institutes of Health National Center for Complementary and Alternative Medicine.
Study section members are chosen based on their demonstrated competence and achievements in their study area, including activities such as research activity and publication in scientific journals. Hurdle is using his grant funding to develop a treatment for C. difficile, one of the most widespread and dangerous infections in the U.S. He is working with colleagues at St. Jude Children's Hospital in Memphis, Tenn.
Read more about the Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section here.
Posted July 31, 2013